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 The possibility to work for three months in Istituto Nazionale dei Tumori in Milan gave 
me the opportunity to develop practical skills in Palliative Care, which I felt I lacked. It also 
provided me the chance to work in a renowned institution, side by side with specialists with a 
vast experience in providing advanced holistic care to cancer patients. The opportunity was both 
appealing and challenging. My main goals were: to  develop skills in the comprehensive 
assessment of pain and other symptoms from cancer and its treatment; to monitor patients for 
adequacy of symptom relief; to improve communication techniques mainly in illness 
understanding, prognosis and end of life; to learn more about clinical research in palliative care 
and if possible, to participate in clinical studies, and finally to integrate multidisciplinary teams in 
different settings of palliative care provision. 
During my 3 months’ internship in the Palliative Care, Pain Therapy and Rehabilitation 
Unit, I’ve worked in the Outpatient Clinics, Day Hospital, Hospice, Inpatient Consultation Team 
and Home Care Team, and I have also developed research work within the Department.  
I value this experience as it changed my perception of Palliative Care, and reassured me 
that this subject of medicine is rigorous, based on robust evidence, and has a remarkable  impact 
in quality of life and survival of patients living with  advanced illness. I’ve worked dedicatedly to 
this final report  in order to describe, in the most realistic way, what drives me, which are my 
goals, and how I’ve achieved them during this internship. The research project concerning 
palliative sedation resulted in an article published in the Journal of Pain and Symptom 
Management. 
In the end, I feel that I’ve benefited immensely  from  this experience, gathering skills and 
competences to improve palliative care in my daily practice and to give my contribution to the 
















A oportunidade de trabalhar no Istituto Nazionale dei Tumori em Milão teve origem na 
vontade de desenvolver competências em Cuidados Paliativos que sentia em falta, e a ideia de o 
fazer numa Unidade de renome, com especialistas experientes na prestação de cuidados 
avançados e holísticos a doentes oncológicos, foi para mim cativante e desafiante. Os principais 
objetivos por mim delineados foram: desenvolver competências na avaliação detalhada da dor e 
de outros sintomas derivados do cancro e das suas terapêuticas; monitorizar a adequação do 
alívio sintomático; melhorar técnicas de comunicação, nomeadamente no entendimento da 
doença, prognóstico e fim de vida; acompanhar e participar em projetos investigação clínica em 
cuidados paliativos; integrar as diferentes equipas multidisciplinares em diferentes contextos da 
prestação de cuidados paliativos.  
Durante o meu estágio de 3 meses na Unidade de Cuidados Paliativos, Controlo da Dor e 
Reabilitação, trabalhei na Consulta Externa, Hospital de Dia, Hospice, equipa intra-hospitalar e 
cuidados domiciliários, tendo ainda desenvolvido trabalho de investigação dentro deste Serviço.   
 Valorizo esta experiência pelo modo como alterou a minha perceção dos Cuidados 
Paliativos, reafirmando o quanto esta área da medicina é rigorosa, baseada em evidência robusta 
e como a sua aplicação tem um impacto notável na qualidade de vida e sobrevivência da pessoa 
com doença avançada.  
 Trabalhei dedicadamente na elaboração deste relatório, procurando descrever de modo 
realista o que me motiva, quais são os meus objetivos e como os alcancei durante este estágio. 
O trabalho de investigação desenvolvido no tema da sedação paliativa resultou num artigo 
publicado no Journal of Pain and Symptom Management. 
No final, sinto que aproveitei ao máximo esta experiência, reunindo aptidões e 
competências para a melhoria dos cuidados paliativos na minha prática diária, procurando assim 












A great part of the unforgettable experience I had in my 3 months in Milan, I owe it to 
people. I owe it of course to every person in whose life I was allowed to enter. Besides their illness, 
their frailty, their suffering, they’ve accepted me into their privacy, and with them I’ve learned so 
much. But I also owe it to the many others that took part in this history and to whom I therefore 
I am infinitely grateful :   
 
To Manuel Luís Capelas, for giving me the idea to go to Istituto Nazionale dei Tumori (INT), for 
allowing it to become real and for believing in me and in my will to become a Palliative Oncologist.  
 
To all the professors of Catholic University, for their commitment to the students, for their 
rigorous teaching of Palliative Care subjects and for encouraging us to contribute to the 
development of quality Palliative Care in Portugal.   
 
To Augusto Caraceni, for allowing me to work with him and his incredible team, for guiding me, 
teaching me and inspire me to keep working in this field.   
 
To Luigi, Francesca, Silvia, Riccardo, Federica, Tiziana and Paola, they made me feel I was part of 
the team. Thank you for your daily dedication to patients, for inspiring me in doing the same, for 
helping me and teaching me. To them, but also to all the INT Palliative team, who welcomed me 
and integrated me, I am forever grateful.   
 
To the best friends I could ask for, thank you for your constant support and affection. 
 
To my life companion, Eduardo, thank you for your endless love and permanent presence, no 
matter how apart we are.  
 
A word of tremendous gratitude to my family, my parents, my brother, my grandparents. You’ve 
made me who I am. Thank you for always believing in me and for allowing me to follow my 
































































































ADL – Activities of Daily Living 
BTAs – Bone Targeted Agents  
DH – Day Hospital  
EAPC – European Association of Palliative Care 
ECOG – Eastern Cooperative Oncology Group 
ESMO – European Association of Medical Oncology 
INT – Istituto Nazionale dei Tumori 
NRS – Numeric Rating Scale 
OC – Outpatient Clinics  
PC – Palliative Care 
PS – Performance Status 



























































The history of Palliative care begins with the attention given to the care of the 
dying. In the 1960s, Dame Cicely Saunders established the modern hospice movement in 
the United Kingdom, based on the careful observation of terminally ill patients (1). With 
a great sense of humanity and a strong determination, Dr. Cicely Saunders raised 
awareness on the importance of preserving dignity and quality of life of patients with 
incurable illnesses, advocating at the same time the need to empower research and 
training in this area. As brilliantly  described by David Clark in the Foreword of the book 
“Watch with me” (2), Cicely Saunders held on her life’s work an enduring preoccupation: 
a concern for the relationship between personal biography, the spiritual life and ethics of 
care. Contemporaneously, Elizabeth Kübler-Ross, an American psychiatrist, defended the 
urge to treat people in the end of life with respect, openness and honest communication 
(1). In 1974, Dr. Balfour Mount coined the term “palliative care” to label his hospital-
based service (3), and introduced Saunders’ innovations into academic teaching hospitals 
(1). Since then, palliative care has evolved from a philosophy aimed at improving care for 
terminal patients, to a professional specialty that provides comprehensive care for 
patients and their families.  
// 
 
Cancer is the second leading cause of death worldwide, and the disease which 
incidence has increased the most. In 2015, 1/6 of all causes of death worldwide were due 
to this illness that we tend to call as “modern”, because it was in the last decade that it 
has taken its leading role, as a result of industrialization, control of infectious diseases 
and the increase of life expectancy in developed countries. In fact, in the last century 
we’ve almost duplicated lifespan and augmented cancer incidence in 30%.  
Cancer was first described during the Hippocratic period, using the term Karkinos 
from the Greek work “Crab”. This word originated from the similarity that Hippocrates 
found between this crustacean, buried in the sand with its legs open and a protruding 
mass with filled blood vessels around. Nevertheless, it was the Greek word onkos, usually 
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used to describe tumors, that originated the modern term of oncology. It meant “mass” 
or “burden”(4). Cancer was therefore seen as a burden that the body carried. However, 
Hippocrates and his initial conception of cancer were far to resemble the entity we now 
know.  
Cancer represents a wide group of diseases with high complexity and variability, 
originated from the process of carcinogenesis. This concept defines a sequential model 
according to which cancer develops, inexorably, from a small and localized tumor, to an 
advanced disease which progresses to metastasis and, in its natural history, to death. In 
this process, there are now well recognized distinct capabilities that cells have to acquire 
do gain advantage and to proliferate, which have become the targets to the development 
of early detection methods and personalized therapies, intended to be minimally 
deleterious to the host.  
But talking about cancer will always and above all be to talk about people. Only 
the word makes us tremble, wishing that this scourge doesn’t knock at our door. We 
connect this terrible disease to suffering. And no one wishes to suffer. And so the biggest 
challenge in dealing with people with cancer will be how to best address and alleviate 
their needs.  
// 
 
Being a medical oncologist in practice has been teaching me a great deal about 
human suffering. It has also made me realize that being an oncologist is as much about 
knowing the disease and how to manage it, as about mastering symptom relief and 
providing an active supportive care to the patient and to the family. Moreover, addressing 
the emotional, social and spiritual needs of the person has showed me to be equally 
important as approaching the physical ones, in order to achieve an adequate relief of 
suffering. From an educational perspective, I’ve learned the importance of recognizing 
and assessing “total pain”, Dame Cicely Saunders’s concept that incorporates  physical, 
emotional, social and spiritual domains (5). 
However, despite the need to offer patients a meaningful, rigorous and 
individualized care, physicians are often more comfortable dealing with the medical and 
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fact-based realms (6), lacking an honest communication with the patient and the families, 
that encompasses their needs. Doctors tend to focus on the patient’s disease, not on the 
person. The magnitude of this issue rises as it is not restricted only to cancer patients, but 
to the majority of the severe and chronic illnesses of our time. People will live all their 
lives with that illness, and with a tremendous burden of distress (7). And so, the question 
imposes: what are we doing to relieve that burden?  
In Portugal, a lot of work has been undertaken in the last years towards giving 
shape to the World Health Organization’ definition of palliative care: “an approach that 
improves the quality of life of patients and their families facing the problem associated 
with life-threatening illness, through the prevention and relief of suffering by means of 
early identification and impeccable assessment and treatment of pain and other 
problems, physical, psychosocial and spiritual” (8). Despite the efforts, there are still 
important differences in needs of palliative care and a significant asymmetry in the 
coverage of these needs (9). Besides, as stated by Dr. Diane Meier, in many settings the 
little palliative approach that is being offered, is to terminal patients. But the majority of 
patients who need palliative care, aren’t dying (7).   
As I felt impelled to work towards the improvement of Palliative Medicine in my 
country, I felt the need to learn more. During my first year as a resident, I started 
searching for training and learning opportunities, and underwent a post-graduate course 
in grief and bereavement and also an advanced course in pain management. Through this 
path, I started my palliative care masters in the Catholic University in Lisbon in 2016.  
To obtain the master’s degree, the choice of doing a research-project or a clinical-
practice internship is offered. In the beginning of the classes, with the opportunity to 
study palliative care, the ideas were bursting in my head and the prospect of developing 
a research project was appealing. Nevertheless, I felt it wouldn’t fulfil my needs of 
developing practical skills I felt I lacked, and that would be crucial to what is my daily 
practice. Also, as I wish to integrate palliative care teams, I felt essential to learn on the 
field, with skilled teams, so I could give a meaningful contribution. Moreover, I presumed 
that, if I chose the right place to make an internship, I would have the opportunity to 
develop research competences that also felt to be critical for my construction as an 
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oncologist and palliative care practitioner. After sharing my goals with my Master’s 
professor Manuel Luís Capelas, the idea of applying to an internship in INT in Milan came 
immediately and, with his help, I was accepted to work in the Palliative Care Department 
of this Institute for 3 months.  
 
This report pretends to describe the activities developed in my  3 month 
internship in INT. It is organized in 4 sections: General goals and expected learning 
outcomes; Internship Host Institution; Internship Description; Conclusions and Final 
Remarks. In the first section I will describe the main goals I’ve set to this internship, as 
well as skills and competences I expected to acquire. In the “Internship Host Institution” 
section, I’ll describe briefly the history of Palliative Care in Italy and the role of INT in 
developing this field. Then, I intend to describe thoroughly how each section of the 
Palliative Care, Pain Therapy and Rehabilitation Unit is established, how it works and who 
comprises each team. In the third section, my aim is to report the activities in which I was 
enrolled in each section of the Unit during my internship and to describe the observed 
population, in terms of characteristics and opportunities to learn from them. In Final 
Remarks  and Conclusions , I acknowledge the impact of this internship in my practice, 
how the proposed goals were met and the path I intend to follow having acquired this 
amount of experience.  
 








Before the beginning of my internship, I’ve established the following goals based 
on two important documents for an oncologist resident that wants to develop advanced  
skills and competences in Palliative Care:  The ESMO / ASCO Recommendations for a 
Global Curriculum in Medical Oncology Edition 2016 (10) and the White Paper from de 
EAPC on Core competencies in Palliative Care (11). These four main goals will be the 
basis of my training in a high-level Palliative Care Unit. 
 
- Symptom management and control – To be able to screen, assess, prevent and manage 
different symptoms (such as pain, fatigue, delirium, malignant bowel obstruction, nausea 
and breathlessness), by following senior doctors and nurses in different settings 
(outpatient clinics, inpatient consultation team, hospice, home care), and to learn with 
their approach to patients’ symptomatic issues. Also, I would like to acknowledge and 
address differences in what concerns the type of patients and their phase in the disease 
trajectory, according to setting. Particularly, I will try to understand the types of 
medications used and other existing therapeutic approaches, as well as difficulties 
encountered, for example, by the inpatient consultation team when addressing patients’ 
symptoms. 
 
- Psychosocial and spiritual approach - To meet patients psychological, social and 
spiritual needs, and the ones of their families. To approach family as unit of care. To be 
involved in a multidisciplinary approach in these fields, learning how to assess and 
manage these matters, also developing and improving effective communication skills 
about illness understanding, prognosis and end-of-life preparation. The department 
team comprises, besides doctors and nurses, psychologists, physiotherapists, chaplain, 
shiatzu professional, social assistant, volunteers, neurology consultant. My goal here will 
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be to understand the importance of each of these specialists for the approach of the 
psychological and spiritual dimension of each patient, and how, in a practical way, it 
improves the quality of the provided care.  
 
- System implementation and functioning – To gain awareness about a complex and well 
established palliative care system, how it is structured, how it works, and how it is 
integrated in the community.  To this, I will gather oral information provided by the 
teams that work in the different departments and settings. 
 
- Research – I will work in a Palliative Care Unit in which the research field is extremely 
well known for its quality and high–standard research, centered in improving patients’ 
well-being and quality of life. Here, I would like to dedicate some of weekly working hours 
for getting involved in research work, essentially in clinical and translational settings, and 
to develop some research work, or help developing some ongoing research project, this 






Knowledge, skills and competences to be acquired  
 
- Appreciation of the role of palliative care interventions across the trajectory of illness 
for patients with cancer; 
- Recognition of the effects of palliative care interventions integrated into decision-
making for anticancer treatments; 
- Familiarity with the role of multidisciplinary approach in the care of patients with 
advanced cancer; 
- Ability to contribute actively in a structured way in a multidisciplinary team to plan 
and manage care for patients and their families; 
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- Ability to screen and to perform a comprehensive assessment of main symptoms 
(pain, dyspnea, fatigue, anorexia, nausea, delirium, depression, anxiety, diarrhea, 
constipation), as well as competences-based management 
- Ability to elaborate and discuss an integrated plan of care; 
- To recognize the unique aspects of end-of-life care, such as decision-making 
processes, symptom management, involvement of family members and spiritual 
aspects; 
- To understand and be able to approach main issues of end-of-life care, beyond 
symptom control, such as legacy, finishing business, grief, with patients 
and with their families; 
- Ability to communicate efficiently with patients and their families and other 
caregivers, discussing main issues, preferences, desires and fears, and to manage 
them; 
- To be able to identify criteria, such as triggers, for referral to specialized palliative 
care teams; 

























The Palliative Care Unit of Istituto Nazionale dei Tumori in Milan retains the history 
of palliative care in Italy. The movement was initiated in the 70’s, under the initiative of 
professor Vittorio Ventafridda. It was with the good will and financial support of non-
profit organizations and private charities like The Floriani Foundation, and the Italian 
League Against Cancer, that palliative care become a reality. The first progresses started 
at the homecare level, mainly due to organizational, economic, social and cultural 
reasons. It was in the 90’s that palliative care became established and legislated, and that 
a national plan on organization of these services was designed. In 2001, palliative care 
became recognized as an essential level of assistance, obliging this care to be provided to 
the population, for free, according to a structured model of network assistance (12). In 
the last years, palliative care in Italy is continuously developing, with the improvement of 
palliative home care teams, covering most of the territory, and also with the creation of 
a substantial number of hospices, with the Lombardy region accounting for the majority 
(13). The first hospital hospice comprised in a scientific institute was born in 2006, in 
Istituto Nazionale dei Tumori di Milano, named Hospice Virgilio Floriani, thanks to the 
support of this Foundation. Currently, The Palliative Care, Pain Therapy and Rehabilitation 
Department of INT in Milan is a referral Centre for palliative care both nationally and 
internationally, that brings together academics, healthcare professionals, the 
community, caregivers and patients, with a multidisciplinary team dedicated to providing 
high quality support and best possible quality of life for cancer patients and their families. 
 
Nowadays, the Palliative Care, Pain Therapy and Rehabilitation Unit of Istituto 
Nazionale dei Tumori, comprises different sections,  with specialists who provide 
assessment  and management of cancer-related symptoms, loss of function and family 
support, having as main goal the restoration of optimal patient functioning in multiple 
life domains, including physical, social, emotional and spiritual. During my internship I had 
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the opportunity to accompany work in the following services: 
- Outpatient Clinics; 
-  Day Hospital; 
- Inpatient Consultation Team; 
- Hospice; 
- Palliative Home Care Team. 
 
 
Figure 1- Diagram of the Palliative Care, Pain Therapy and Rehabilitation Unit team 
 
Figure 1 tries to illustrate the organization of the medical staff working in the 
Palliative Care, Pain Therapy and Rehabilitation Unit of INT. It is, however, important to 
point out that this was the organization during my stay in the Unit, but the divisions are 
not fixed, meaning that some doctors rotate between different departments 
occasionally, so they keep developing work in each of the departments. For example, Dr. 
Cinzia Martini is the supervisor of the Hospice, but sometimes Dr. Silvia LoDico can be 
working with her. Also, for example, Dr. Paola Bracchi works in Hospice, but she can also 
be repositioned in the Home Care Team. Therefore, most doctors in this Unit have a deep 


























The PC Outpatient Clinics (OC) provides outpatient PC services in INT. It comprises 
medical offices, the day hospital of PC with specialized nurses and a doctor assigned, 
rehabilitation services and psychology and psycho-pedagogy assistance. 
It works from 8 am to 5 pm, weekdays, being assured by 4 medical specialists, and an 
Outpatient Clinics coordinator: 
- Ernesto Zecca, M.D. – Outpatient Clinics Coordinator 
- Francesca Ricchini, M.D. 
- Silvia LoDico, M.D. 
- Paola Bracchi, M.D. 
- Fabio Formaglio, M.D. 
 
The patients referred to the OC come essentially from other departments in the 
Institute: Medical Oncology, Surgery, Radiotherapy, being referred mainly patients with 
poor symptom control and with advanced-stage disease. Most of the patients that are 
referred have stage IV disease, so they are not receiving cancer-specific therapy with 
curative intent, being mostly under palliative intent therapy or under best supportive 
care.  Treatment-related symptoms are managed mostly in the Supportive Care in Cancer 
Unit. Therefore, the majority of symptoms that are assessed and treated in the 
Outpatient Clinics are most often tumor-related, consequence of past treatments, or due 
to other non-yet clarified motives. 
Moreover, thanks to early Palliative Care referral models, the Clinics seeks to avoid 
late referrals to Palliative Care. These models try to identify patients who meet 
appropriate criteria, and incorporate, besides type of cancer, cancer staging and place of 
metastases, symptom burden, functional capacity, psychological impact and social 
support. The importance of early referral of cancer patients to palliative care has been a 
target of extensive research in the last years. One of the most remarkable studies is the  
randomized clinical trial by Temel et al (14), published in 2010, with an outstanding 
impact in the perception of Palliative Care. This study was carried out in patients with 
metastatic non-small cell lung  cancer, and compared standard cancer treatment versus 
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cancer treatment with concurrent palliative care started in the 8 weeks following the 
diagnosis. This study not only met its primary goal of improvement in quality of life of 
patients receiving early palliative care compared with patients only receiving standard 
oncologic care, but also showed how it reduces aggressive treatments in the end of life, 
as chemotherapy treatments, emergency departments visits, hospitalizations and time in 
hospice. But maybe the most unexpected and therefore publicized result was the 
increased survival of cancer patients when receiving early palliative care. More evidence 
exists supporting this data (15–17), and therefore confirming how an early and 
simultaneous approach to the cancer patients increases their quality of life, their 
endurance throughout cancer treatment, their acceptance of the clinical situation, as well 
as it allows a constant support and assessment of needs, essential for challenging 
decisions in more advanced phases of the disease and in the end of life.  
In the Outpatient Clinics, one example of an integrated model of referral, concerns 
the attention to bone health and the prevention of complications related with bone 
metastases, mainly skeletal events, bone pain and hypercalcemia. Therefore, every 
patient with bone metastases is referred to the Outpatient Clinics, in order to receive 
bone targeted therapy, when no contraindications exist, with the adequate follow-up and 
interventions, whenever necessary. Among these, I would highlight periodical 
assessment of calcium and vitamin D, with supplementation when necessary, and 
assessment of renal function to adequate hydration or dose adjustment. To prevent a 
rare but important complication of the administration of drugs, the osteonecrosis of the 
jaw, every patient undergoes a visit to the stomatologist and orthopantomography to 
assess dental health. The results of the establishment of a protocol in INT for odontoiatric 
prevention of osteonecrosis of the jaw in patients under bisphosphonates therapy was 
published in 2008 in Annals of Oncology (18), reporting a 75% reduction in this adverse 
event.  
In the Outpatient Clinics, each appointment has a predicted duration of 20 minutes. 
The frequency of visits depends on a variety of factors, mainly symptom control, 
therapeutics monitoring and degree of disease progression and expected clinical 
deterioration. Each appointment is written down informatically in a pre-designed model 
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that comprises: Motif of the appointment; Diagnosis; Clinical synthesis (with anamnesis 
and physical exam); diagnostic procedures, diagnostic and treatment prescriptions, and 
next appointment.  The assistance provided to cancer patients in the Outpatient Clinics 
is an example of the importance of early referral to adequate symptom management and 
to the prediction and prevention of adverse outcomes. The OC works closely with the 
other sections of the PC Unit, ensuring adequate referral to different setting, as Hospice 





The Day Hospital (DH) of Palliative Care works every weekday from 8 am to 3 pm, and 
is integrated in the Outpatients Clinics, being under the same coordination. It is an open 
space with 6 armchairs and 3 beds, a working room for nurses and a cabinet for doctors. 
The DH has a capacity to enroll between 25 to 30 patients at a time.  
Here, patients come referred mainly by the Palliative Care Team itself: whether by 
the home care team or by the OC. The Day Hospital provides crucial assistance since it 
allows the provision of immediate support in terms of symptom control, with the 
opportunity to perform several therapeutics in different ways of administration 
(intravenous, intramuscular, subcutaneous). For patients that come with, for example, 
uncontrolled pain, immediate relief, opioid titration and rotation are all possible tasks to 
be performed. Furthermore, when there is need to undergo intravenous hydration, ionic 
reposition, diuretic therapy, corticosteroid therapy, blood transfusion or bone targeted 
therapy, all these can and are performed in this setting. Diagnostic and therapeutic 
procedures can also be performed in DH, like ultrasound-guided paracentesis, 
thoracentesis, as well as placement of long duration catheters to drain ascites or pleural 
liquid. Frequently there’s also need to collect blood samples to check, for example, for 
anemia, signs of infection or ionic disturbances justifying new or worsening symptoms.  
The DH team comprises 4 skilled nurses, an assistant Doctor and one doctor in 
training, as well as a technical assistant.  Together, doctors and nurses make a clinical 
evaluation of all patients in every visit, monitoring mostly symptom control, and 
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developing a treatment plan. With every patient’s visit to the DH, nurses fill in the Morse 
fall scale (19) (Attachment 1) for identifying fall risk factors, make an evaluation of 
patient’s autonomy in daily activities, and complete the ESAS scale, validated to the Italian 
language by researchers of the Palliative Care team of the Institute (20,21) (Attachment 
2). All this information is recorded in the written file of each patient and updated to each 
visit.  
It is important to point out that families are also a fundamental part of the decision-
making process, when addressing different aspects of care for patients with advanced 
disease in DH. With the patient’s consent, families can be present all the time, and 
involved in the clinical process, giving an important contribution to the understanding of 
symptom burden, limitation in ADLs and more social or psychological dimensions that are 
not always perceptible in DH assessment. In DH, it is usual to undergo family conferences, 
together with the social assistant and the psychologist. These are opportunities to discuss 
critical decisions of the advanced care planning, as deciding for home care or hospice, 
defining priorities and approaching end-of-life issues. The anticipation of critical events is 
also crucial and makes part of the whole process.  Activation of home care assistance or 
transference to hospice is a common procedure initiated in the DH setting.  
	
The Outpatient Clinics, together with the Day Hospital, undoubtedly represent an 
example of an organizational model with a profound impact in QoL of patients and their 





The inpatient consultation team of INT is composed by a medical doctor, Dr. Luigi 
Saita, and nurse Federica Rusconi. Both work every weekday from 9 am to 4 pm. The 
consultation team assesses inpatients throughout the institution, when requested by 
each hospital department, helping with symptom control, evaluating appropriateness 
and need for rehabilitation services, assisting in discharge planning and developing an 
appropriate plan of care that’s within the patient and the family’s needs.  
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The inpatient consultation team is also a bridge between palliative care services and 
every surgical and medical hospital department. The team provides a direct route to 
admit patients into different palliative care sectors at discharge (as outpatient clinics or 
home care), as well as in transferring patients to hospice, when meeting adequate 
criteria, namely considerable symptom burden that requires constant monitoring by a 





Hospice Virgilio Floriani in INT is a tribute to the priest and founder of the Floriani 
Foundation, who financed the construction of this sector. The infrastructures where the 
hospice is localized, comprise also the headquarters of the Palliative Care Department, 
with medical and research private offices, secretary, meeting room and working space 
for the PC team. The Department is linked to the hospice through two different doors, 
one that goes directly to one of the Hospice corridors, and other that goes to the nurses’ 
working space.  
The Hospice is provided with 10 individual rooms with private bathrooms, TV-screen, 
a desk, a closet and sofa bed, as well as shared spaces: a kitchen, a living room, a room 
for reading, and a small open terrace with table and chairs.  
The Hospice team is, once again, multidisciplinary and consists of doctors, nurses, 
psychologist, psychopedagogist, physiotherapists, occupational therapists, shiatzu 
therapist, chaplain and social assistant. Hospice is a very particular setting, where 
providing total care is an everyday goal. Symptom control, psychological support, 
advance care planning, coordination of care and development of coping strategies are 
provided under the best and most updated evidence, with several concluded and ongoing 
clinical trials that aim to contribute to improve the quality of the provided palliative care.  
The well-being of patients that come to the Hospice is one of the key concerns. The 
harmony of the space stands out, with plants along the corridors, and silence or some 
peaceful music. Often some cultural events take place in hospice, like concerts, reading 







At the time of my internship, the palliative Home Care Team comprised a team of 3 
doctors, 5 nurses, a physiotherapist, a  psychologist and a social assistant. The team works 
every week day from 8 am to 4 pm, being on call after that, and also during night periods 
and weekends. Patients followed by this team are referred mainly from the Outpatient 
Clinics or Day Hospital, but also after Hospice discharge or by the inpatient consultation 
team. The Palliative Home Care Team works in the areas around INT,  being that each 
doctor and nurse is responsible for some areas, and provides assistance to patients living 
in the areas assigned for them. Medical visits happen, usually, twice a week, but the 
periodicity depends on level of assistance. Each patient is classified as having need of 
high, medium or low level of medical assistance, being this classification very dynamic, 
meaning a patient can pass from medium level for high level in a week, needing daily 
doctors and nurses’ visits. The periodicity of nurse’s visits also depends on this 
classification and is usually more frequent than doctors’ visits, going from twice daily to 
weekly.  
It is maybe needless to say that a patient can only be referred to the Palliative Home 
Care Team if they have a caregiver responsible for them. In fact, a key factor for the 
success of the work developed by the Home Care team is the autonomy provided to 
family and caregivers in the assistance to the patient.  To all the caregivers, a first home 
appointment is made, with the doctor and nurse assigned for that patient, in which all 
the team functioning is explained, phone numbers provided, as well as clarification of 
doubts, fears and concerns about having a patient with an advanced illness at home. A 
complete anamnesis and physical exam are also performed. In this appointment, a bag 
with different kinds of medication is given to the caregiver, with a thorough explanation 
of their purpose, dose, frequency and way of administration. A subcutaneous catheter is 
placed in every patient, and instructions about how to administer each drug provided 
through this way are provided to the caregiver (Attachment 3). A complete assessment 
of needs is also made in this appointment, both physical, social, psychological and 
spiritual, and meeting these needs will be one of the main concerns of the team 
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(Attachment 4). In the following visits, reassessment of those needs, symptom 
management and assistance to family and caregivers will be given, among other tasks 
that are variable depending on each case. Blood exams are made whenever necessary 
and therapeutic scheme readjusted if needed. The team aims to decrease the number of 
visits to the emergency department made by these patients, trying to prevent and to 
anticipate more difficult situations, instructing caregivers on how to act in specific  





The Palliative Care Department of INT has a long reputation in developing well-design 
research trials, published in high impact Journals, that provide critical evidence to support 
practices in the field of Palliative Care. Furthermore, the Department organizes periodical 
training and scientific activities, both nationally and internationally and is also the 
headquarters of the Palliative Care Research Centre and of the Research Network of the 
European Association for Palliative Care (EAPC). The Department contributes actively for 
the organization of the Congress of the Italian Society of Palliative Care (Società Italiana 
di Cure Palliative - SICP) and the Congress of EAPC. 
 The main responsible for the research work in this Department is Dr.Cinzia 
Brunelli, with background and expertise in statistics, being a researcher who develops 
extensive work in the area of health care, particularly in cancer pain. Currently, she works 
in the Palliative Care Department in INT and jointly with the European Palliative Care 
Research Center, Department of Cancer Research and Molecular Medicine, Faculty of 
Medicine, Norwegian University of Science and Technology, Trondheim, Norway.	
	 Some remarkable papers have been published by the Department (22–30), with 
important contributions to other ones (31,32), mainly in fields of expertise of its 











It is not possible to describe the Palliative Care, Pain Therapy and Rehabilitation Unit 
of INT without talking about its volunteers. The volunteers of the Milanese section of the 
Italian League Against Cancer (Lega Italiana per la Lota contro I tumori – LILT) are a 
cornerstone in the assistance provided to cancer patients through all INT but with a 
notable role in the Palliative Care Unit. Their readiness to help in every setting, always 
with a tender word to give, not only to patients and families but also to the health 
professionals that everyday struggle to provide care within advanced illness, is 
remarkable. And they do it free of charge, in a true sense of citizenship and service to 
others. Their gestures are humble, discrete but extremely useful, and go much further 
than serving water and food in the waiting rooms and to inpatients. Some examples that 
I had the opportunity to testify during my stay in INT, include such diverse activities as:  
attendance to the cancer patients within the Institute, accompanying them for 
appointments and exams; supporting patients in hospice,  just with their presence or 
registering patients’ biographic notes, writing letters that they wish to send to loved ones, 
reading for them; giving support to families; visiting patients in their homes, as part of 
the Palliative Home Care Team, providing company, so important for patients who are 
not close to loved ones; helping doctors or nurses in bureaucratic and frequently 
exhausting tasks, easing jobs as organizing patient’s databases, so useful to further 
evaluation of results; distributing quality of care  and symptom evaluation’ questionnaires 
to both outpatients and inpatients. For me, the work of the volunteers was impressive, 
making me realize that each one of them, with their knowledge, tastes and attributes, 









In the following section I will try to describe how I’ve decided to organize the time 
I was given in the Institute, together with the host team, reviewing thoroughly the 
activities I’ve developed and in which I’ve been engaged, the population I’ve 
observed, the teams with who I’ve worked and how all this have  allowed me to 
progressively meet the general goals which I’ve proposed, as well as to acquire the 
knowledge, skills and competences that I’ve projected for this internship.  
During my 3 month’ internship, it was given to me gradual self-sufficiency in 
execution of different tasks, in order to overcome initial goals.  Thereby, I’ve observed 
in an autonomous, tutored way patients in different settings: outpatients, home 
patients, inpatients. This opportunity allowed me to develop skills that I’d never 




Having defined my goals and learning outcomes, I’ve developed with my 
internship supervisor and the whole team, an internship schedule for my 13 weeks, with 
780 (31,2 ECTS)  working hours, that I’ve followed scrupulously. This plan was organized 
based on a weekly schedule of 40 working hours, in the host institution, plus 20 hours a 
week dedicated to study, research homework, organize data and start the elaboration of 
the final report. The 520 hours spent working in the host institution were divided as 
follows:  
- Outpatient clinics: 2 weeks (80 hours – 3,2 ECTS) 
- Day Hospital: 2 weeks (80 hours – 3,2 ECTS) 
- Inpatient consultation team: 2 weeks (80 hours – 3,2 ECTS) 
- Hospice: 2 weeks (80 hours – 3,2 ECTS) 
- Home care team: 2 weeks (80 hours – 3,2 ECTS) 








term aims focus on preventing pain progression and skeletal related events (SREs) (39). 
Together, these approaches have as final purpose to improve patients’ QoL. An approach 
according to the analgesic ladder was taken, with the use of opioid and non-opioid 
analgesics, short course corticosteroids, referral to radiotherapy or to other 
interventional strategies, for the treatment of localized metastatic bone pain. 
International societies, as ESMO (40), recommend also the use of bone targeted agents 
(BTAs)  (bisphosphonates and RANK ligand inhibitor denosumab) part of the therapeutics 
regimen for bone pain, but mainly for reducing SREs. Of the 84 patients with bone 
metastases that I’ve observed in the OC, 74 (88%) were under BTAs, 48 (65%) being 
Denosumab and 26 (35%) zoledronic acid. In fact, some phase III studies comparing 
zoledronic acid to denosumab have showed a bigger delay to onset of moderate/severe 
pain with the last one (41).  These therapeutics were prescribed and administered in the 
OC, with periodical assessment of  renal function as well as calcium and Vitamin D 
measurements and adequate supplementation when needed. Every patient, before 
starting BTAs, were referred to the stomatologist for dental assessment.  
  As stated by Hui et al (3), the OC is a hallmark of oncology-palliative care 
integration, for how they provide to cancer patients access to specialist palliative care 






I’ve spent two and a half weeks in DH, following the work of Dr. Silvia LoDico. She 
introduced me to everyday activities in this department and gave me the possibility to 
understand how symptom control can only be managed effectively if approached in a 
multidimensional way. For this, the anamnesis was always a critical part of the 
assessment, and provided almost all the needed information, being at the same time 
therapeutic itself. Dr. LoDico gave me progressive autonomy to engage and lead 
appointments with patients,  as well as to carry close examination. Thus, I’ve learned how 
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to adequately assess needs and goals, to adequately manage most common symptoms 
related with advanced cancer and to meet patient’s desires and hopes.  
Most of the patients I had the opportunity to meet in DH would come often to the 
OC, sometimes every day, so I got the opportunity to develop some bond with few of 
them. The patients enrolled for follow-up in DH were mostly patients with advanced 
disease and relevant symptom burden. I came to realize that this was an opportunity for 
many patients to better understand their disease, its impact, to clarify doubts and to 
define a treatment plan that would meet each patient’s goals.  
 
	 I’ve followed a total of 37 patients (Table 1), with median age of 73 (IQ 25%-75% 
59-77), 62% female patients. Many of these patients would visit DH twice a week.  
 From the patients I had the opportunity to follow, main motives for admission and 
follow-up in DH were clinical monitoring and treatment infusions, due to poor control 
symptoms and high burden of disease, needing monitoring and treatment adjustment. 
I’ve separated pain control in a different motif of admission (Table 1), because these 4 
patients were being followed exclusively for pain management, and they’ve represented 
significant learning moments for me, of how opioid titration, use of pain adjuvants, and 
control of irruptive pain, could be successfully managed in DH. When working in the DH, 
I’ve attended one abdominal catheter placement for drainage of ascites, and one thoracic 




























Once more, most of patients in DH had stage IV disease (86%) mainly of the 
gastrointestinal tract (42%) (Figure 9), being the most common place of metastases the 
























TOTAL NUMBER OF PATIENTS 37 
Women, nr. (%) 23 (62%) 







FIRST VISITS 9 
MAIN MOTIF OF ADMISSION 
  



































TOTAL NUMBER OF PATIENTS 31 
Women, nr. (%) 18 (58%) 








FIRST VISITS 9 
VISITED DEPARTMENTS  
  
Mesenchymal and rare tumors and Melanoma 9 
Ear, Nose and throat 1 
Radiotherapy 1 
Hematology 1 
Medical Oncology 8 
Gynecology 1 
Urology 1 
Colorectal Surgery 1 
Thoracic Surgery 6 





Figure 11 - Patient distribution according to primary tumor location (Inpatient Team) 
 
From the 31 patients, 2 died during the observation period, 4 were transferred to 
hospice due to progressive disease with high symptom burden and 4 were discharged 
with assurance of palliative home care team support.  
It is of particular importance to underline that, previously to each transference of an 
inpatient to the home or hospice setting, a family conference was undertaken, in order 
to clarify the current clinical situation, discuss prognosis, answer to doubts, assess needs 




Dr. Cinzia Martini is the Hospice’s medical coordinator, and her daily tireless and 
systematic work contribute to the success of the provided care in this setting. I’ve worked 
with Doctor Martini during my 3 weeks of stay in this sector.   
The criteria to be admitted in Hospice are several, but some requirements are 
needed. For example, patients should not be under any active cancer treatment, and be  
in need for specialized care.  
I’ve divided the main motives for recovery in Hospice as shown in Figure 12, since 




















Figure 12 - Motives for admission in Hospice	
 
Often, more than one of these motives was present. High symptom burden of 
difficult ambulatory management was the main issue to prompt admission in Hospice, 
but the lack of home support or the rapidly progression of cancer which would precipitate 
worsening symptoms were frequent scenarios.  
As can be seen in Table 3, patients were most often referred from the day hospital 
of Palliative Care or from another department of INT, through the evaluation of the 
inpatient consultation team. Of note that the most common department from where 
patients were referred was the Medical Oncology Department (89%) .  
During my period in Hospice, I’ve observed a total of 35 different patients (Table 
3), with median age of 70 years (IQ 25%-75% 62-77), 46% female. The average time of 








































 Almost all patients (89%) had stage IV cancer and most commonly lung or bone 
metastases, being the most frequent origin of the primary tumor the gastrointestinal 
tract (Figure 13). As confirmed by the ECOG/PS of the admitted patients (80% with PS  3 
or 4) these were predominantly patients with severely impaired functionality, as 
expected.  
 
TOTAL NUMBER OF PATIENTS 35 
Women, nr. (%) 16 (46%) 








NEW ADMISSIONS 17 
ORIGIN  
Day Hospital of Palliative Care 10 
Palliative Home Care Team 7 
Another INT department 9 
Another Hospice 5 




Figure 13 - Patient Distribution according to primary tumor location  (Hospice) 
	
	
When analyzing symptom burden, the most frequent poorly controlled symptoms 
were, in order of frequency: dyspnea, nausea, vomiting (more often due to malignant 
bowel obstruction), fatigue, pain and impaired oral intake.  Management of these 
symptoms was regularly complex, and made in a multidisciplinary and staged way. A 
symptom assessment with the help of the ESAS form (Edmonton Symptom Assessment 
Scale) (Attachment 2) was used to help record a regular monitoring of different 
symptoms, and Palliative Performance Scale (PPS) to evaluate functionality and 
dependency (Attachment 6). Additionally, on admission, a cancer specific palliative 
prognostic scale was usually applied, as the Prognosis in Palliative Care Study (PiPs) (42–
44), the Palliative Performance Index (PPI) (45) or the Palliative Prognostic Score (PaP) 
(46). Generally, these prognosticators encompass information regarding the diagnosis, 
symptoms, general health, blood results and the clinician’s estimate (Attachment 7, 
Attachment 8). This data are extremely helpful in making critical decisions and, together 
with communication with the patient and family (47), provide better prognostication 
then the assessment of the most commonly used way to define prognosis for oncologists, 
the ECOG/PS. This last way of assessing patient’s condition and deciding for further 
approaches can be extremely discordant, and therefore, if taken alone, can be a 




















Having in consideration the results provided by the above-mentioned tools, and 
after a careful assessment of patients and their caregivers needs, wishes and preferences 
as well as patient’s life expectancy, an advanced care plan was designed, setting goals 
and priorities. In hospice, needs were met in a structured way, applying  Maslow’s 
hierarchy of needs, which allowed a comprehensive approach in order to achieve, not 
only symptom control and patient’s comfort, but also to allow the patient to fulfill further 
domains, like engaging in activities that give him/her pleasure.  For example, it would be 
extremely difficult to talk with a patient about a trip he would like to make in his last 
month of life, if he is suffering with severe pain.  
In Hospice, I’ve had the opportunity to witness how different fields of care come 
together in the promotion of the patient and their families’ well-being, whose work is 
based on needs, not prognosis, regardless of the goal being discharge, or the provision of 
comfort in the end of life. A multidimensional and individualized approach was the rule 
and teamwork a reality. Every morning a quick briefing was made with nurses, to 
communicate complications from the night before. Then, a round was made to check on 
every room and then patients were divided by the different members of the medical 
team. During my time in Hospice, besides Dr. Martini, I’ve worked with a colleague in 
training from Anesthesiology, Dr. Riccardo Di Rosso. In the first days I accompanied Dr. 
Martini and Dr. Di Rosso in their activities, but soon I started being responsible for some 
patients. Every note and therapeutic was recorded informatically. Under my charge I had 
also admissions and discharges. Our activities were extremely variable, depending on the 
patient. For example, I’ve participated in a central venous catheterization, for a patient 
in need for intravenous antibiotics without peripheral venous access.  
From the 35 patients I’ve followed in Hospice, 27 (67,6%) died during my stay. 
Uncontrolled and intolerable dyspnea and delirium were the two most frequent reasons 
to undergo palliative sedation in Hospice, performed in 20% of the patients who died. 
This procedure was undertaken in a monitored and strict way. The patient, with an 
advanced and irreversible disease, would present with an intolerable and refractory 
symptom, meaning that it was not controlled with the available medical procedures. 
Sedation was started usually in an intermittent way, with the main goal being the least 
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sedation for the maximum control of symptoms. This refers to situations where urgent 
sedation was not the case, as would be the case for example of massive bleeding. 
Sedation was monitored using the Richmond Agitation Sedation Scale (RASS) 
(Attachment 9) and symptom control through clinical observation. Assessments of 
consciousness, motor activity or agitation were routinely made. The most frequently used 
drug for sedation was Midazolam. 
  
Every member of the hospice provided holistic and targeted care. The morning 
period was usually the time for the medical visits, changes in medical therapeutics and 
execution of procedures by both medical and nursing teams. The afternoon was reserved 
for the work of physiotherapists, shiatzu therapist, phycologist. The patient and the 
caregivers received routinely care and assistance, in order to cope with the disease and 
its boundaries, as well as with the end of life. Short time goals were continuously 
reviewed and adjusted, and priority was given to life story and legacy activities. 
Nevertheless, some specific cases marked me, maybe for how they challenged palliative 
care in one of its most fundamental goals: the relieve of suffering. As an example, I 
mention a 56-year-old woman with stage IV breast cancer, transferred from the Medical 
Oncology Department. Her cancer had spread to the lymph nodes, bones, lungs, liver and 
now, arising as a right-side hemiparesis, metastasis in the brain. This woman was severely 
anxious, suffering with back pain, breathless and not able to take care of herself. In 
hospice, we could help her treating some sources of her “total pain”. But her existential 
distress was much more challenging. Some dimensions of human suffering can be 
extremely demanding and sometimes even frustrating for health care providers. The 
importance of teamwork and shared decisions regarding complex end-of-life situations 
was one of the biggest lessons I’ve learned in this setting.  
During my work in Hospice,  3 patients were discharged, all home and with 








For 3 weeks, I’ve followed the work of the Palliative Home Care Team, side by side 
with Dr. Tiziana Campa, a true expert in what concerns needs  and symptom’ 
management of cancer patients with advanced disease in the home setting. Dr. Tiziana 
taught me how the environment that surrounds the patient is key to his/her wellbeing, 
and so being able to keep the patient comfortable in a familiar space is both challenging 
and reassuring.  
Every day we would visit patients according with a previously organized agenda, that 
would be adjusted depending on patients’ needs and evolution. I’ve followed a total of 
16 patients, median age 78 (IQ 25%-75% 74-83). As can be seen in Table 4, most patients 
had advanced disability as evaluated by ECOG/PS.  
 















During my work with this team, 7 new patients were enrolled in the Home Care Team, 
most referred from the Day Hospital of Palliative Care. Main motives for admission were 
symptom control (44%), advanced disability due to progressive disease (44%) and rapidly 
TOTAL NUMBER OF PATIENTS 16 
Women, nr. (%) 8 (50%) 








NEW ADMISSIONS 7 
ORIGIN  
Day Hospital of Palliative Care 9 
Hospice  2 
Outpatient Consultation Team 2 
Medical Oncology Department 2 
Another Hospital 1 
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progressive illness expected to trigger intense burden of disease (56%), being that more 
than one motif could be present for the same patient. Every patient had metastatic (75%) 
or advanced disease (25%), with high variability in primary cancer, being breast cancer 
the most frequent. Most common places of metastases were the lung and pleura (44%), 
followed by bone (25%). The most uncontrolled symptoms, reported in Figure 14 were 
associated with location of primary cancer and metastasis. Fatigue and anorexia/cachexia 
were the most frequent, followed by delirium, pain and dyspnea. More than one 
symptom was often present, and in Figure 14  are only reported the most remarkable 
and demanding in what concerns symptom control.  
 
 
Figure 14 - Main symptoms assessed in Home Care patients 
 
Our average number of visits per week to each patient was 2, and average time of 
follow-up was 33 days. From the 16 patients that I’ve observed, 5 died during this period. 
Palliative sedation was performed in 3 cases, 2 for refractory dyspnea and one due to 
intractable hyperactive delirium. Midazolam was the drug of choice for performing 
palliative sedation. One patient died in the emergency department.  
I’ve realized during this part of the internship how  Palliative Home Care assistance is 
not only crucial for patient’s comfort, but also for families and other relatives, not just as 
a help and guide for symptom management, but also as a support in the last days of life, 
















provided by the Palliative Home Care Team is essential to clarify treatment goals as well 




Two of the hallmarks of the Palliative Care Unit are its multidisciplinarity and the 
importance given to team work. The weekly meetings that take place in the Unit are a 
portrait of this, being excellent opportunities to exchange knowledge, discuss challenging 
cases, share doubts regarding certain patients, in a truly educational way.  
Each Tuesday takes place the Hospice meeting, and each Friday the Palliative Home 
Care Team meeting. Each meeting counts with the attendance of the entire health team 
who works in that section, including volunteers assigned to each setting. The team 
discusses each patient and each team member is welcomed to contribute to the 
reassessment of each patient’ advanced care plan. The provision of comfort and meeting 
needs are the priorities of the discussions that take place weekly. Debriefings are also 
performed, whenever needed, mainly after occurrences that would be desired to have a 
different outcome. 
The Hospice team gathers weekly to update advanced care planning set up for each 
patient, to define strategies, discuss concerns, share expectations presumed from 
communication with the patient. 
The Home Care Team gathers also weekly to discuss advanced care planning for each 
patient, redefine intensity of care, according to events occurred in the previous week, to 
share feedback concerning each patient, family and/or caregivers, to list unsolved 
problems and needs to be tackled. 
The Unit also organizes weekly Journal Clubs, but since my internship was during the 
holiday season (July to September) I didn’t have the opportunity to be part of any.  
Every of these meetings were extremely productive and enriching and the 
contribution of every intervenient was important to structure multidimensional 






During 3 weeks of my internship, I’ve worked in partial time in research in the 
Palliative Care Unit. My main goals during this period were to get familiar with the 
methodology and development of a research project and to be actively involved in such. 
This was undoubtedly an important time of learning in what pertains the design of a 
research study, which is set from a question to which an answer is to be found. With 
the help of Dr. Alessandra Raimondi and the supervision and extensive contribution of 
Dr. Brunelli and Dr. Caraceni, a research project was developed in the field of palliative 
sedation, conducted by this Department as a multicenter observational longitudinal 
study. The study intended mainly to compare palliative sedation in Hospice and Home 
settings, to understand patients’ clinical characteristics, decision making processes in 
what concerned palliative sedation techniques, practical aspects, indication, used 
methodology and monitoring.  Data were already collected, from several Palliative Care 
Units in Italy. Dr. Cinzia Brunelli analyzed data and reported the results, as we developed 
bibliography research, elaborated both introduction and conclusions and developed the 
final paper. The work was laborious but extremely rewarding, being published in March 
2018 in the Journal of Pain and Symptom Management, entitled: Palliative Sedation In 
Terminal Cancer Patients Admitted To Hospice Or Home Care Programs: Does The 



















I could describe exhaustively how the experience of PC in INT made me achieve  
my proposed goals, how every experience in each section contributed for this, but I think 
the best way of demonstrating the type of experience I’ve lived, and how I’ve learned, is 
by telling a story. This story I’ve retained in my mind, for it is an example of suffer, of 
extraordinary courage, of devotion, but most of all, it is the story of extraordinary human 
beings.  
I will describe this man, let’s call him Antonio. In the summer of 2017, he arrived 
to the Outpatient Clinics of palliative care, hands with his wife, sent by his medical 
oncology assistant. He had just been diagnosed with stage IV pancreatic cancer, with liver 
and lung metastases. He was a singer. He lived in an old apartment, big windows and a 
little balcony, with his wife and his 19-year-old son. When he came to the PC Clinics, he 
was exhausted. He was also in pain, and for this, he couldn’t rest at night. In the following 
3 weeks, he came to the Day Hospital twice a week, so we could control his pain and find 
the right treatment for him. Despite our success in controlling his symptoms, the disease 
was progressing quickly, and he was becoming more asthenic, sarcopenic and dependent. 
After 3 weeks, he was coming to the DH in a wheelchair and could only be comfortable  
when lying down. At this point we’ve decided to pass the case to the Home Care Team. 
At first, his wife was very resistant about this decision. She couldn’t stop feeling we were 
giving up. After long conversations and clarifications, she agreed with us, and decided to 
be his main caregiver. She learned how to administer several subcutaneous drugs, with 
the help of the HC team nurses, that provided also the kit with several medicines that 
could be useful. She learned when and how she should administer each one of them, and 
that she could always call and ask for help. The home care doctor responsible for him, 
Doctor Paola Bracchi, visited him twice a week in the first weeks. She adjusted the opioid 
route of administration to a patch when Antonio started being very reluctant to take 
meals, and after 30 days, she started visiting this family almost daily, since the patient 
was starting to have dyspnea. The wife was now very anxious, as she felt she couldn’t 
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manage this symptom properly and therefore not able to have his husband comfortable 
at home anymore. Wife and son confessed that they were also afraid of watching him 
dying, because they felt they weren’t prepared to assist him at that point. Antonio had 
now some periods of clarity but often he was sleeping. His breathing was progressively 
harder.  That’s when the team and the family decided that the best option would be to 
move him to hospice. With the help of the whole team, wife and son were always present 
and supported. With symptom control, they could feel calmer and more comfortable 
being around him. Antonio spent 17 days in hospice before dying, peacefully, surrounded 
by his wife and son. Some weeks after Antonio’s death, they both visited the hospice, to 
thank the whole team and leave some homemade cookies. They sat in the living room for 
some time, in silence, except for the twittering of birds. For them, that place was a 
sanctuary, a place they felt was full of life and hope. They were really brave, and we all 
told them how we admired their strength and devotion. They were at peace. Nothing 
could be most rewarding. Thanks to this amazingly well-designed structure, this family, 
whose path they didn’t choose, was allowed to cross it calmly and devoted to what really 



















According to the Oxford Dictionary, a synecdoche is a figure of speech in which 
the part is made to represent the whole. In Medicine, we often tend to appeal to this 
literary device, probably influenced by our training, by our systemized mentality, and by  
the so-called organ-site approach (49). However, the only way to properly address and 
relieve our patients’ suffering, is by considering the totality of the person, reminding once 
more the pain’s global concept of Dame Cicely Saunders (5). As stated by an oncologist 
colleague “Holistic care is a challenge, it is demanding, tiring and difficult, but it is the only 
way to practice oncology with dignity and success”(49).  
This approach demands us to be capable of recognizing the other’s vulnerability, 
leading to a compassionate presence towards the person in need (50). This genuine 
attitude avails from the understanding that, often, a disease emerges in a person’s life, 
little by little, and suddenly takes the leading figure. For the patient, the universe turns 
into a low ceiling, a sky without stars and without the infinite. The disease can be 
profoundly claustrophobic and its voice monotonous and terrifying (51). But who 
prepared us to deal with suffering, with vulnerability, and even more, with mortality? Leo 
Tolstoi’s Ivan Ilitch (52) is a personification of suffering and the loneliness of dying, of the 
human’s inability to deal with the end of life, and it is therefore  an appeal to ethics, to 
compassion, to the respect for human dignity. Also, Atul Gawande wisely reminds us that 
death is not failure. Death is normal, and it is the natural order of life (53). But our modern 
society has insisted on disagreeing, as since the end of the eighteenth-century death 
started being seen by the medical teams as sign of defeat, and so to be avoided at all 
cost. Every patient was treated until the last heartbeat, without a clear discussion about 
goals of care. Death became hospitalized, dissected to little steps (54), and the limitations 
of medicine were forgotten, as that all care is not good care, sometimes it is even harmful 
and burdensome for the patient, the relatives and the staff. Palliative Medicine has 
emerged to host the person in suffer, and more than talking about death and dying, to 
focus on having the best quality of life possible (55).  
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My last 2 years have been absorbed in reading and studying about palliative care. 
For this, the palliative care masters helped me tremendously. But I lack practical training. 
And so, my choice of doing an internship in the Palliative Care, Pain Therapy and 
Rehabilitation Department of Istituto Nazionale dei Tumori in Milan, besides my 
knowledge of the Italian language, was driven by the will to work in a high-level palliative 
care centre, with the opportunity to develop research work of high quality and high 
standard and with teams that work at all levels of assistance and in an integrated way. 
These teams also have a vast experience working with cancer patients, in a country with 
a social, cultural and economic ground very close to the one in Portugal, where the main 
difficulties and challenges probably converge. But the choice to internship at this Unit 
was also driven by the person that leads it. Dr. Augusto Caraceni is a worldwide renowned 
name in the field of palliative care and pain therapy, who has been devoting his work to 
creating excellency in the palliative care field, both nationally and internationally. As 
stated in the webpage of the Institute “His clinical and research experience include the 
palliative treatment of advanced cancer, neurological complications of cancer, cancer 
pain classification assessment and treatment with particular attention to opioid 
analgesics, and symptom control with a special interest in delirium. He is the author of 
more than 160 scientific articles in indexed journals, on palliative care, cancer pain and 
cancer care (…)”. Professor Caraceni is a cornerstone that makes this centre a reference 
in palliative care, offering a complete and holistic assistance to the patient, with a strong 
commitment and contribution in research activity, innovative therapies, and education. 
 
The Palliative Care internship in INT represented for me an enormous opportunity 
of discovery and resilience. But a great challenge brought by this experience was to 
understand how I could extrapolate everything I’ve learned to my country, to my hospital 
and to my daily reality. Not having a clear answer yet, there are some aspects I would like 
to emphasize, that have made an impression. In first place, the role of the volunteers: 
they are crucial and make a tremendous difference in the daily work of the PC Unit. In 
second place, I highlight the exemplary organization system of the PC Unit.  Every section 
work in straight coordination, allowing an easy referral of each patient to the most 
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appropriate type of care. The communication between each member of the PC team was 
constant, clear and precise, and the work always made towards the patient’s benefit. At 
last, I underline the teamwork of all the people with who I’ve worked with. Often the 
working schedule left little time to educational or research activities. Nevertheless, and 
so that this work was not jeopardized, the team would readjust whenever one team 
element was under tight deadlines or in need to attend to courses or a congress or finish 
papers. This working model of true teamwork and support have inspired me to keep and 
foster a similar practice in my daily activity.  
In the end of this internship, the balance couldn’t be more positive: I considered 
fulfilled the general and specific goals that I’ve set to this period, namely in what concerns 
a multidisciplinary approach to the palliative cancer patient, combining knowledge and 
technique, to the sensibility of recognizing the person in suffering, and to adequately 
address it. The ascending acquisition of independence, always with orientation, have 
allowed me to gain the necessary autonomy to gain confidence in the practice of 
Palliative Care, as well as management and decision skills that have globally enriched my 
clinical ability.  
This 3 months experience have largely exceeded my initial expectations. I’ve 
learned so much, but mostly how an integrated model of palliative care can, indeed, make 
a tremendous difference in the quality of life and in the survival of the person living with 
cancer, as well as considerably reduce health associated costs.  
I finish this report thankful for the past and sighting the future. My wish is to become 
a palliative oncologist, and while the Master in Palliative Care established solid ground of 
knowledge, skills and competences that will guide me in my future practice,  giving me 
indispensable tools, this internship has taught me how to use them on behalf of the 
others. From here, I believe that my dedication, passion and teamwork will make a 
difference. Ultimately, my wish is to be able to give my contribution to the delivery of top 
quality palliative care in my country. My optimism and confidence come from the 
certainty of the words of Lewis Carroll “One of the deep secrets of life is that all that is 
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